ICC 2021

Michael Thompson, Speaker at Cancer Congress
Keynote Presentation
Michael Thompson, University of Toronto, Canada

High grade serous ovarian cancer (HGSOC) histologic subtypes make up the majority of epithelial ovarian cancer and 85% of cases are diagnosed at advanced stages, in which the 5-year relative survival could be as low as 20%. Unfortunately, only 20% of patients are diagnosed at sta [....] » Read More

Alain Chapel, Speaker at  Cancer Conferences
Keynote Presentation
Alain Chapel, Institute Of Radiological Protection And Nuclear Safety, France

The late adverse effects of pelvic radiotherapy concern 5 to 10% of patients, which could be life threatening. However, a clear medical consensus concerning the clinical management of such healthy tissue sequelae does not exist. Our group has demonstrated in preclinical animal mo [....] » Read More

Mauriane Maja, Speaker at Cancer Congress
Oral Presentation
Mauriane Maja, de Duve Institute, UCLouvain, Belgium

Breast cancer mortality is almost exclusively due to metastatic disease. Better molecular characterization of the primary tumor is therefore crucial for a good prediction of the clinical outcome. Breast cancer cells are characterized by aberrant lipid accumulation and metabolism. [....] » Read More

Anna Lian, Speaker at Oncology Conferences
Oral Presentation
Anna Lian, Brigham and Women’s Hospital/Harvard Medical School, United States

Immunotherapy has reshaped the landscape of cancer treatment, showing promising treatment responses in melanoma. Currently, there are no pathological features which consistently predict treatment responses in melanoma; existing studies have involved small cohorts and shown confli [....] » Read More

Odiegwu Chukwujekwu Nwabueze C, Speaker at Oncology Conferences
Oral Presentation
Odiegwu Chukwujekwu Nwabueze C, Nnamdi Azikiwe University-Nnewi Campus, Nigeria

Will be Updated Soon...

Eleni Petsalaki, Speaker at Oncology Conference
Oral Presentation
Eleni Petsalaki, University of Crete, Greece

During cell division, the mitotic spindle consists mainly of microtubules (MTs) and is essential for accurate distribution of the genetic material to the two daughter cells. Errors in spindle formation can lead to incorrect separation of chromosomes that is associated with tumori [....] » Read More

Kalliopi Megari, Speaker at Cancer Conferences
Oral Presentation
Kalliopi Megari, Aristotle University of Thessaloniki, Greece

Post chemotherapy cognitive impairment (PCCI), is referred to a decrease in neuropsychological performance of neurocognitive measures after chemotherapy for the treatment of cancer. Chemotherapeutic drugs are often affecting both normal and cancer cells and the cause of cognitive [....] » Read More

Izabela Mlynarczuk Bialy, Speaker at Cancer Conferences
Oral Presentation
Izabela Mlynarczuk Bialy, Medical University of Warsaw, Poland

The process of entosis is not widely known phenomenon, that can impact diagnosis and prognosis of cancer. The phenomenon is characterized by the active invasion of one cell into another and the formation of “cell in cell structures” (CIC), with the participation of Rh [....] » Read More

Sergio Alexandre Alcantara Dos Santos, Speaker at Oncology Conference
Oral Presentation
Sergio Alexandre Alcantara Dos Santos, Sao Paulo State University UNESP, Brazil

Although the carcinogenesis is frequently linked to genetic background, exposure to environmental risk factors has gained attention as the etiologic agent for several types of cancer. The intrauterine microenvironment has been described as preponderant factor for offspring health [....] » Read More

Ana Luiza de Castro Conde Toscano, Speaker at Cancer Congress
Oral Presentation
Ana Luiza de Castro Conde Toscano, Emilio Ribas Infectious Diseases Institute, Brazil

Kaposi's sarcoma (KS) is a mesenchymal tumor, caused by herpes virus type 8 (HHV-8), and a characteristic neoplasm of acquired immunodeficiency syndrome (AIDS). After the emergence of AIDS in 1980, a more aggressive form of the disease, more common among homosexual or bisexua [....] » Read More

Paola Marcato, Speaker at  Oncology Conferences
Oral Presentation
Paola Marcato, Dalhousie University, Canada

Long non-coding RNAs (lncRNAs) are emerging targets for the diagnosis and therapeutic treatment of cancer. LncRNAs are non-protein-coding transcripts that regulate gene expression by modulating chromatin structure or by interacting with other RNA species. Additionally, they exhib [....] » Read More

Luigi Marongiu, Speaker at Cancer Congress
Oral Presentation
Luigi Marongiu, University of Heidelberg, Germany

Colorectal cancer (CRC) is a major burden for the Public Health worldwide. It has been proposed that CRC has an infectious aetiology but no statistical association has been observed between disease and microbial species. On the other hand, modification of the relative prevalence [....] » Read More

Romi Gupta, Speaker at  Oncology Conferences
Oral Presentation
Romi Gupta, University of Alabama at Birmingham, United States

Pancreatic ductal adenocarcinoma (PDAC) is the fourth- leading cause of cancer-related deaths in the United States and is expected to become the second-leading cause by 2020. The five-year disease-free survival rate for patients with PDAC is extremely low and has remained <10% [....] » Read More

Tapasree Roy Sarkar, Speaker at Oncology Conference
Oral Presentation
Tapasree Roy Sarkar, Texas A&M University, United States

Will be Updated Soon...

George Zachos, Speaker at  Cancer Congress
Oral Presentation
George Zachos, University of Crete, Greece

Chromatin bridges are strands of missegregated chromatin connecting the anaphase poles or daughter nuclei and have been linked to tumourigenesis. In response to chromatin bridges in cytokinesis, cells delay abscission, the severing of the narrow cytoplasmic canal that connects th [....] » Read More

Yevheniia Radzishevska, Speaker at Cancer Congress
Poster Presentation
Yevheniia Radzishevska, Kharkiv National Medical University, Ukraine

The aim of presentstion will to demonsrate the relationship between nosological forms of the primary and second neoplasms in patients who have undergone special treatment for cancer, and who have developed second neoplasms three and  more years after the end of treatment. It [....] » Read More

Yves Marie Robin, Speaker at  Cancer Congress
Keynote Presentation
Yves Marie Robin, Biology-pathology wing, Oscar Lambret Cancer Center, France

A substantial number of lesions in soft tissue pathology requires diagnostic precision for adequate patient care management and follow-up. Also, margin status of surgical specimens must be unequivocally defined, preferably intra-operatively, because of the tight relation which ex [....] » Read More

Marina De Rosa, Speaker at Cancer Conference
Keynote Presentation
Marina De Rosa, University of Naples Federico II, Italy

Will be Updated Soon...

Mehrasa Nikandish, Speaker at Oncology Conferences
Oral Presentation
Title : Types of cancer
Mehrasa Nikandish, University of Georgia, Georgia

As it is obvious, nowadays cancer is one of the most common disorders all around the world and nobody can ignore the importance of getting educated about them, types, how they spread around the body and how they can be treated and also some procedures after treatment because ever [....] » Read More

Ozlem Dilek, Speaker at Oncology Conferences
Oral Presentation
Ozlem Dilek, University of the District of Columbia, United States

Small-molecule based probes have been used to tag biomolecules site-selectively on molecular basis to enhance diagnostic approaches in cancer. We designed a small molecule-based probe which incorporated with the carbonyl moiety of biomolecules through a click reaction to form a f [....] » Read More

Sathish Kottaisamy, Speaker at Oncology Conference
Oral Presentation
Sathish Kottaisamy, Guru Gobind Singh Indraprastha University, India

Technological advancements and recent discoveries in cancer therapy have decreased cancer-related mortality. But the principal objective of improving quality of life through advanced cancer treatments is compromised by poor management of pain (especially Neuropathic Pain (NP)) in [....] » Read More

Dellasie Aning, Speaker at  Cancer Congress
Oral Presentation
Dellasie Aning, Panalove LLC, Ghana

Technological advancements and recent discoveries in cancer therapy have decreased cancer-related mortality. But the principal objective of improving quality of life through advanced cancer treatments is compromised by poor management of pain (especially Neuropathic Pain (NP)) in [....] » Read More

Darko Katalinic, Speaker at Cancer Congress
Oral Presentation
Darko Katalinic, Josip Juraj Strossmayer University of Osijek, Croatia (Hrvatska)

Will be Updated Soon...

Wei Qiu, Speaker at Oncology Conferences
Oral Presentation
Wei Qiu, Loyola University Chicago, United States

Hepatocellular Carcinoma (HCC), a primary type of liver cancer, remains one of the deadliest malignancies worldwide. Despite decades of targeted therapy advancements, the currently approved medications for advanced HCC provide patients with limited clinical benefits. One major ob [....] » Read More

Watsapp